NDTP
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Jul 10 closing price
Capitalization
9.76M
OTLC
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Jul 21 closing price
Capitalization
20.46M
34 days until earnings call
Interact to see
Advertisement

NDTP vs OTLC

Header iconNDTP vs OTLC Comparison
Open Charts NDTP vs OTLCBanner chart's image
NDT Pharmaceuticals
Price$0.05
Change-$0.00 (-0.00%)
Volume$12.08K
Capitalization9.76M
Oncotelic Therapeutics
Price$0.05
Change-$0.00 (-0.00%)
Volume$109.01K
Capitalization20.46M
NDTP vs OTLC Comparison Chart in %
Loading...
NDTP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NDTP vs. OTLC commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NDTP is a Hold and OTLC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (NDTP: $0.06 vs. OTLC: $0.05)
Brand notoriety: NDTP and OTLC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NDTP: 487% vs. OTLC: 121%
Market capitalization -- NDTP: $9.76M vs. OTLC: $20.46M
NDTP [@Biotechnology] is valued at $9.76M. OTLC’s [@Biotechnology] market capitalization is $20.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NDTP’s FA Score shows that 1 FA rating(s) are green whileOTLC’s FA Score has 0 green FA rating(s).

  • NDTP’s FA Score: 1 green, 4 red.
  • OTLC’s FA Score: 0 green, 5 red.
According to our system of comparison, NDTP is a better buy in the long-term than OTLC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NDTP’s TA Score shows that 1 TA indicator(s) are bullish while OTLC’s TA Score has 3 bullish TA indicator(s).

  • NDTP’s TA Score: 1 bullish, 6 bearish.
  • OTLC’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both NDTP and OTLC are a bad buy in the short-term.

Price Growth

NDTP (@Biotechnology) experienced а +17.31% price change this week, while OTLC (@Biotechnology) price change was -13.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.39%. For the same industry, the average monthly price growth was +15.71%, and the average quarterly price growth was +33.77%.

Reported Earning Dates

OTLC is expected to report earnings on Aug 25, 2025.

Industries' Descriptions

@Biotechnology (+2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OTLC($20.5M) has a higher market cap than NDTP($9.76M). OTLC YTD gains are higher at: 43.143 vs. NDTP (15.094).
NDTPOTLCNDTP / OTLC
Capitalization9.76M20.5M48%
EBITDAN/A-3.84M-
Gain YTD15.09443.14335%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A79.2K-
Total DebtN/A13.3M-
FUNDAMENTALS RATINGS
NDTP vs OTLC: Fundamental Ratings
NDTP
OTLC
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
9640
P/E GROWTH RATING
1..100
10095
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NDTP's Valuation (5) in the null industry is somewhat better than the same rating for OTLC (53). This means that NDTP’s stock grew somewhat faster than OTLC’s over the last 12 months.

NDTP's Profit vs Risk Rating (100) in the null industry is in the same range as OTLC (100). This means that NDTP’s stock grew similarly to OTLC’s over the last 12 months.

OTLC's SMR Rating (97) in the null industry is in the same range as NDTP (100). This means that OTLC’s stock grew similarly to NDTP’s over the last 12 months.

OTLC's Price Growth Rating (40) in the null industry is somewhat better than the same rating for NDTP (96). This means that OTLC’s stock grew somewhat faster than NDTP’s over the last 12 months.

OTLC's P/E Growth Rating (95) in the null industry is in the same range as NDTP (100). This means that OTLC’s stock grew similarly to NDTP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NDTPOTLC
RSI
ODDS (%)
Bearish Trend 4 days ago
38%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
68%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
64%
Bullish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
53%
Bullish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
64%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
47%
Bullish Trend 4 days ago
85%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
65%
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NDTP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IHGP0.02N/A
+2.99%
Interact Holdings Group, Inc.
MAORF2.15N/A
N/A
Mandarin Oriental International Ltd.
PYHOF0.07N/A
N/A
Playmates Holdings Ltd.
TELIF0.30-0.02
-5.76%
TELESCOPE INNOVATIONS CORP.
TISCY12.50-3.07
-19.72%
Taisei Corp.

NDTP and

Correlation & Price change

A.I.dvisor tells us that NDTP and CADL have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NDTP and CADL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NDTP
1D Price
Change %
NDTP100%
+17.31%
CADL - NDTP
31%
Poorly correlated
-2.52%
IDRSF - NDTP
22%
Poorly correlated
+20.00%
LIXT - NDTP
22%
Poorly correlated
-3.45%
MMIRF - NDTP
15%
Poorly correlated
N/A
MBXBF - NDTP
7%
Poorly correlated
+0.50%
More

OTLC and

Correlation & Price change

A.I.dvisor tells us that OTLC and THAR have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OTLC and THAR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLC
1D Price
Change %
OTLC100%
-1.22%
THAR - OTLC
25%
Poorly correlated
-1.54%
DRUG - OTLC
20%
Poorly correlated
-0.08%
CANF - OTLC
20%
Poorly correlated
-1.44%
MMIRF - OTLC
15%
Poorly correlated
N/A
NDTP - OTLC
2%
Poorly correlated
+17.31%
More